Aktienanalyse zu Inspire Medical Systems Inc (INSP)INSPInspire Medical Systems Inc

Inspire Medical Systems, Inc. is a medical technology company. The Company focuses on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is neurostimulation technology that provides safe and effective treatment for moderate to severe obstructive sleep apnea. The Company's closed-loop solution continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Inspire Medical Systems is currently not a strong buy due to its recent price decline and mixed analyst ratings. The current price is $68.79, with a forward P/E of 59.17 indicating high valuation expectations. The RSI is at 47.165, suggesting the stock is neither overbought nor oversold, which may indicate a wait-and-see approach. The main risk is the significant year-to-date change of -25.45%, reflecting potential volatility ahead.

5 analysts cover INSP: 3 rate it Buy, 2 Hold and 0 Sell. The average price target is 145.31.